Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again

Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.
By DENISE GRADY from NYT Health https://ift.tt/2UfjXIc
via IFTTT
Stem Cells, Regulation and Deregulation of Industry
Source The New York Times
Làm đẹp Blog 247